A snake bares its fangs in front of a medicine bottle.

credit: James Rodrigues

Could snake venom usher in a new era of band-aid?

Proteins in snake venom could support blood clotting at the site of injury.
Nathan Holwell
| 2 min read

Download the infographic here

Could snake venom usher in a new era of band-aid?
Illustrated by James Rodrigues

Big or small, in the kitchen or in an emergency room, flesh wounds and the subsequent bleeding need quick treatment to prevent infection and further complications. The body seals up wounds by creating a clot made of fibrin protein that prevents infection and further loss of blood. Commercial products such as Tisseel and Quikclot Combat Gauze can reduce the time to form a fibrin clot, but these can fail when a patient has impaired blood clotting, hypothermia, or blood that is more acidic than usual. Although usually harmful, snake venom may offer a surprising solution.

Snake venoms are complex mixtures of proteins that can affect a number of human systems, including the central nervous system, the muscular system, and the cardiovascular system. Some venoms are deadly because they create blood clots that circulate through the body as haemostatic clots, or prevent clots from forming at a wound, leading to fibrinolysis and excessive blood loss. In recent years, researchers harnessed the wound sealing properties of snake venom to form stable fibrin clots at the sites of injuries.

Reptilase, an enzyme made by pit vipers, rapidly creates fibrin when mixed with blood. When researchers mixed reptilase with a crosslinking agent, they created a bioadhesive that sticks to a wound and slowly releases reptilase to form a fibrin clot (1). The bioadhesive dramatically reduced the amount of blood lost and shortened the coagulation time compared to no treatment in animal models. 

Another research group used two enzymes found in snake venom as a wound sealant. The first enzyme, ecarin, helps form blood clots. The second, textilinin, helps prevent the body from breaking down clots too quickly. Using mouse models and a hydrogel containing ecarin and textilinin, they found that the hydrogel slowed bleeding and reduced blood loss compared to untreated wounds. They also saw shortenend bleeding times and less blood loss in a mouse model of a bleeding disorder (2).

These types of bandages can be used in different environments to reduce bleeding times and blood loss. The researchers hope that using snake venom to help rather than hurt will usher in a new age of bandages.

References

  1. Guo Y. et al. Snake extract–laden hemostatic bioadhesive gel cross-linked by visible light. Sci Adv  7, eabf9635 (2021).
  2. Yegappan R. et al. Snake Venom Hydrogels as a Rapid Hemostatic Agent for Uncontrolled Bleeding. Adv Healthc Mater, 2200574 (2022).

About the Author

  • Nathan Holwell
    Nathan is a biomedical engineering PhD candidate at Queen’s University and a science journalism intern at DDN.

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue